Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer
Pengfei Xu(Southern Medical University), Chengfei Liu(UC Davis Comprehensive Cancer Center)
Cited by 6
Related Papers
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment
|Journal for ImmunoTherapy of Cancer|2023|64
NOS1 inhibits the interferon response of cancer cells by S-nitrosylation of HDAC2
|Journal of Experimental & Clinical Cancer Research|2019|59
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived models
|Pharmacological Research|2023|20